Stimulation of cardiac cardiolipin biosynthesis by PPARalpha activation

The role of peroxisome proliferator-activated receptor alpha (PPARalpha)-stimulated phospholipase A2 (PLA2) in cardiac mitochondrial cardiolipin (CL) biosynthesis was examined in both in vivo and in vitro models. Treatment of rat heart H9c2 cells with clofibrate increased the expression and activity...

Full description

Saved in:
Bibliographic Details
Published in:Journal of lipid research 2004-02, Vol.45 (2), p.244
Main Authors: Jiang, Yan J, Lu, Biao, Xu, Fred Y, Gartshore, Jennifer, Taylor, William A, Halayko, Andrew J, Gonzalez, Frank J, Takasaki, Jun, Choy, Patrick C, Hatch, Grant M
Format: Article
Language:English
Subjects:
Animals
Anticholesteremic Agents - pharmacology
Cardiolipins - biosynthesis
Cell Line
Clofibrate - pharmacology
Diacylglycerol Cholinephosphotransferase - genetics
Diacylglycerol Cholinephosphotransferase - metabolism
Gene Expression Regulation, Developmental - drug effects
Gene Expression Regulation, Developmental - genetics
Mice
Mice, Knockout
Myoblasts - cytology
Myoblasts - metabolism
Myocardium - cytology
Myocardium - metabolism
Phospholipases A - metabolism
Phospholipases A2
Rats
Receptors, Cytoplasmic and Nuclear - genetics
Receptors, Cytoplasmic and Nuclear - metabolism
Signal Transduction - drug effects
Signal Transduction - genetics
Transcription Factors - genetics
Transcription Factors - metabolism
Transferases (Other Substituted Phosphate Groups)
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The role of peroxisome proliferator-activated receptor alpha (PPARalpha)-stimulated phospholipase A2 (PLA2) in cardiac mitochondrial cardiolipin (CL) biosynthesis was examined in both in vivo and in vitro models. Treatment of rat heart H9c2 cells with clofibrate increased the expression and activity of 14 kDa PLA2 but did not affect the pool size of CL. Clofibrate treatment stimulated de novo CL biosynthesis via an increase in phosphatidylglycerolphosphate (PGP) synthase activity, accounting for the unaltered CL content. Cardiac PLA2, PGP synthase, and CDP-1,2-diacyl-sn-glycerol synthase (CDS-2) activities and CDS-2 mRNA levels were elevated in mice fed clofibrate for 14 days compared with controls. In PPARalpha-null mice, clofibrate feeding did not alter cardiac PLA2, PGP synthase activities, or CDS-2 activity and mRNA level, confirming that these enzymes are regulated by PPARalpha activation. In contrast to mouse heart, clofibrate treatment did not affect the activity or mRNA levels of CDS-2 in H9c2 cells, indicating that CDS-2 is regulated differently in rat heart H9c2 cells in vitro and in mouse heart in vivo. These results clearly indicate that cardiac CL de novo biosynthesis is stimulated by PPARalpha activation in responsive rodent models and that CDS-2 is an example of an enzyme that exhibits alternative regulation in vivo and in cultured cell lines. This study is the first to demonstrate that CL de novo biosynthesis is regulated by PPARalpha activation.
ISSN:0022-2275
1539-7262